| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Mitochondrial long chain fatty acid betaoxidation 0.8397917404057507 2.991839935688038 0.00277301615622 0.8099688203213093 0.3319337732499771 13 Q16836,P23786,Q9BY49,O43772 4 |
| Biotin metabolism including iems 0.9045151489097092 2.752975766382479 0.0059056267557522 0.9710456286714496 0.3319337732499771 8 P11498,P05165,P05166,Q96RQ3,O00763 5 |
| Transsulfuration and onecarbon metabolism 0.6782097353250712 2.65857524768823 0.0078471824922474 0.9910053374316096 0.3319337732499771 17 P00374,P48507 2 |
| Cytoplasmic ribosomal proteins 0.4460889056167827 2.5460496706678635 0.0108949684520724 0.9985712315725715 0.3319337732499771 73 P60866,P62249,P46776,Q9Y3U8,P62241,P27635,P47914,P46777,P18077,P61513,P62917,Q02878,P83881,P46779,P62266,P32969,P62701,Q02543,P62899,P36578,Q07020,P62847,P39023,P84098,P61927,P61313,P18621,P40429,P08708,P62910,P62280,P62857 32 |
| Fatty acid betaoxidation 0.6276064477630805 2.4350986234271734 0.0148877313170192 0.9998728064016988 0.3319337732499771 19 P23786,Q16836,O43772 3 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.7300149587494952 2.3167967619961587 0.020514805515575 0.9999958625791254 0.351941980285499 12 Q96AY3 1 |
| Tryptophan metabolism 0.6200971128597343 1.9495173376759407 0.0512336743607486 0.999999999999978 0.5291836424984978 14 Q16836,Q15392,P35610 3 |
| Hereditary leiomyomatosis and renal cell carcinoma pathway 0.6967460879989327 1.9449099524430529 0.0517858169944458 0.9999999999999843 0.5291836424984978 10 P11177,O00763 2 |
| Ketogenesis and ketolysis 0.7778877134716077 1.8874110111331577 0.0591050652448927 1.0 0.5697268813382952 6 O43772,P23786,P35610 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.7034672161176011 1.852008569098228 0.0640245924200255 1.0 0.5697268813382952 8 P31751,Q15382,Q15334,P42345 4 |
| Ampactivated protein kinase ampk signaling 0.6391949332442107 1.846738861526754 0.0647849965401405 1.0 0.5697268813382952 12 Q13085,P42345,O00763,P14635 4 |
| Retinoblastoma gene in cancer 0.4438414970877024 1.8264930002506568 0.0677760346752467 1.0 0.587392300518805 41 P00374,P15927,P11802,P40938,P33993,P78527,P14635 7 |
| Nrf2are regulation 0.7498541899049996 1.7676245331028482 0.0771236938504071 1.0 0.6292438498878209 6 Q13155,P49841,P48507 3 |
| Eicosanoid metabolism via lipooxygenases lox 0.8074471075898682 1.7513630429176064 0.0798833947141632 1.0 0.6369369338542619 5 Q15067,Q8N8N7 2 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6985575833958753 1.6946521818450022 0.0901414218364624 1.0 0.6693939015727387 7 Q02750,P46734,P42345,Q96KB5,P36507 5 |
| Network map of sarscov2 signaling pathway 0.4869787352306632 1.645447621587765 0.0998775358084118 1.0 0.6982013194467854 24 Q7Z434,Q99829,P42224,Q15382,Q9UGN5,P42345,P31350,Q96J02,P42574,O15226,P14635 11 |
| Mesodermal commitment pathway 0.4994086392875509 1.6396552289818642 0.1010768727623536 1.0 0.6982013194467854 20 Q13085,Q8IWS0,O95071,Q9BYW2,Q9Y2X9,Q8N3C0,P42858 7 |
| Cohesin complex cornelia de lange syndrome 0.5316760073538408 1.63725220067323 0.1015777839328935 1.0 0.6982013194467854 16 Q9Y6X3,Q96FF9,Q9NTI5,P53350,P25054 5 |
| Amino acid metabolism 0.3926862674146097 1.586941351035289 0.1125259283633939 1.0 0.7213557408280036 52 P07814,P11498,P48507,Q96RQ3,Q16836 5 |
| Eicosanoid metabolism via cyclooxygenases cox 0.7593338057029191 1.5570534323481424 0.1194577999213786 1.0 0.7345205110544744 5 Q15067,Q8N8N7 2 |
| Transsulfuration pathway 0.6604735277454276 1.520416837050261 0.1284062454694809 1.0 0.7528130861838199 7 P25325,Q99707,P17174,P48507,P26358 5 |
| Onecarbon metabolism and related pathways 0.5907636580872003 1.497496180476283 0.1342641986942183 1.0 0.7646665792299293 11 Q99707,O43865,P48507,P35790 4 |
| Pparalpha pathway 0.6859404189757878 1.4902432172425393 0.1361602967423718 1.0 0.7681495986031921 6 P23786 1 |
| Target of rapamycin tor signaling 0.6477309992511667 1.4617073151135034 0.1438214318209625 1.0 0.7904492617561295 7 Q15382,P62942,P42345 3 |
| Histone modifications 0.7357040474655334 1.4607700984362555 0.1440785443669199 1.0 0.7904492617561295 5 Q9H7B4 1 |
| Embryonic stem cell pluripotency pathways 0.5640036043962957 1.443490140913055 0.1488824478050932 1.0 0.7991337864479074 12 P31751,Q02750,P62993,P46734,P42345,P28482,P25054,P49841,P36507 9 |
| Integrinmediated cell adhesion 0.4615753250976898 1.3828912382902845 0.1666982172573188 1.0 0.8339613204929668 20 P31751,P60953,Q13177,Q02750,P62993,Q16512,P46734,Q13418,P28482,P41240,P36507,P07384 12 |
| Praderwilli and angelman syndrome 0.6529150737665316 1.3451789881988585 0.1785674399510664 1.0 0.8616910017197387 6 P11802,Q15154 2 |
| Hedgehog signaling pathway wp4249 0.8159506226351385 1.3356041986393257 0.1816786770723033 1.0 0.8616910017197387 4 Q9Y496 1 |
| Mapk cascade 0.650531719838649 1.3346819228652136 0.1819804725198348 1.0 0.8616910017197387 6 Q02750,P62993,P46734,P28482,P36507 5 |
| Nucleotidebinding oligomerization domain nod pathway 0.6189464150143409 1.328548159704361 0.1839970847796679 1.0 0.8616910017197387 7 P55210,Q9P0J0,Q14790,Q9Y2Z0 4 |
| Hepatitis b infection 0.4411964298203294 1.3064196318820005 0.1914098932505625 1.0 0.8798537698938512 22 P31751,Q7Z434,Q02750,P46734,O00571,Q14790,P36507,P42574,P42224 9 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8071229529007844 1.3025047769534517 0.1927438860469807 1.0 0.8798537698938512 4 P07099 1 |
| Il6 signaling pathway 0.5855030709885181 1.2866805736884304 0.1982056468143165 1.0 0.8911802766538442 8 Q02750,P62993,P49841,P36507,P42224 5 |
| Mecp2 and associated rett syndrome 0.4686315199154951 1.242540331741913 0.2140372693963093 1.0 0.920181269130284 16 P35637,P42345,P31943,Q00013 4 |
| Exrna mechanism of action and biogenesis 0.8641523251556205 1.2233897118267292 0.2211825373325644 1.0 0.920181269130284 2 Q9UPY3 1 |
| Circadian rhythm genes 0.3978050834336904 1.2111448558854248 0.2258398926676368 1.0 0.920181269130284 38 Q13330,Q92769,Q06210,Q00839,P11802,P23246,O14744,Q9BQ04,Q15233,Q14103,P78527,P63208,P62136,P17844,Q9NRV9,P49841,Q9BQG0 17 |
| Preimplantation embryo 0.5642832462102257 1.1836870673837208 0.2365369602148956 1.0 0.9396073763704504 8 Q99729,Q92945,Q9P0M6 3 |
| Influence of laminopathies on wnt signaling 0.5300654532664203 1.179450269885325 0.2382189279201141 1.0 0.9396073763704504 11 Q9UPY3,P48729,O60725,P50402,P25054,P49841 6 |
| Omega3 omega6 fatty acid synthesis 0.6149757086665146 1.1779163189981017 0.2388299685757666 1.0 0.9396073763704504 6 Q15067 1 |
| Glutathione metabolism 0.6580907575201148 1.1426775796993685 0.2531724818363972 1.0 0.9561627375827704 5 O75874,P48507 2 |
| Apoptosis modulation by hsp70 0.5536339628981363 1.132046647929864 0.257614823255613 1.0 0.9561627375827704 8 P55210,P55212,Q13546,O95831,P42574 5 |
| Il7 signaling pathway 0.6043315280747947 1.1310132623298008 0.2580495094251525 1.0 0.9561627375827704 6 P49841,P36507,P42224,Q02750 4 |
| Camkk2 pathway 0.5324647369647837 1.1209982837364592 0.2622885929585345 1.0 0.9561627375827704 10 O76024,Q13501,P42345,O00429 4 |
| Cytosine methylation 0.7571744468347263 1.1155842676565444 0.26460012939162 1.0 0.9561627375827704 4 P48735,O75874 2 |
| Integrated cancer pathway 0.4875553465822707 1.1096833886813864 0.2671354834453376 1.0 0.9561627375827704 13 P24941,P11802,P53350,O96017,P42574,P42224 6 |
| Ppar signaling pathway 0.4613196140100439 1.1094171022698125 0.2672502878945315 1.0 0.9561627375827704 15 Q15067,P23786,O15254,Q13418 4 |
| Epo receptor signaling 0.5975818537887272 1.1013035459230325 0.2707645684240178 1.0 0.9561627375827704 6 P42224,P62993,P36507,Q02750 4 |
| Il9 signaling pathway 0.5975818537887272 1.1013035459230325 0.2707645684240178 1.0 0.9561627375827704 6 P42224,P62993,P36507,Q02750 4 |
| Novel intracellular components of rigilike receptor rlr pathway 0.5129679228095472 1.08998553131318 0.2757195175930587 1.0 0.961656709594645 11 Q7Z434,Q92841,Q3LXA3,Q13526,Q13546,O00571 6 |
| Il2 signaling pathway 0.5431367751549123 1.081229333705237 0.2795951126599405 1.0 0.961656709594645 8 P42224,P62993,P36507,Q02750 4 |
| 16p112 proximal deletion syndrome 0.4061279390290681 1.0701495407436556 0.2845520028368529 1.0 0.961656709594645 24 P78371,P46734,P78318 3 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.5223700811215806 1.069959539752847 0.2846375210673113 1.0 0.961656709594645 10 Q13085,Q13057,P42345,O95352 4 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.4769392499927465 1.050204972102149 0.2936238840415552 1.0 0.9630685634328682 13 Q00839,Q9P0M6,P48729,P67870,P25054,P49841 6 |
| Thermogenesis 0.3997547876389882 1.0466157354960448 0.2952768415304421 1.0 0.9630685634328682 23 P23786,O43772,P46734 3 |
| G1 to s cell cycle control 0.3926981923073182 0.9689481004536792 0.3325710845259588 1.0 0.9767788122352744 22 P15927,P11802,Q14181,P33993,P14635 5 |
| Endoderm differentiation 0.4021248352692355 0.9685056413406896 0.3327919029673722 1.0 0.9767788122352744 28 Q13085,Q8IWS0,Q6PD62,O14981,O95071,Q9Y2X9,P46734,Q8N3C0,Q13620,P25054 10 |
| Breast cancer pathway 0.395653703032487 0.9624471247087844 0.3358250515324592 1.0 0.9767788122352744 21 P31751,P11802,Q02750,P62993,P48729,P67870,P42345,P63208,P25054,P49841,P36507 11 |
| Cardiac hypertrophic response 0.4953069718954068 0.9340609996943252 0.3502724281455236 1.0 0.9880326039199204 10 P31751,Q02750,P46734,P42345,P49841,P36507 6 |
| Erk pathway in huntingtons disease 0.7006229388054405 0.9066867409900056 0.3645724769542711 1.0 0.9952830506092764 4 P55210,P42574,P42858 3 |
| Acute viral myocarditis 0.4271997493714201 0.9063036470858824 0.3647751556645935 1.0 0.9952830506092764 15 P55210,P55212,Q13418,P49841,P42574,P42224 6 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.8150183150183157 0.9047517767091174 0.3655969043295541 1.0 0.9952830506092764 3 Q15382,P42345 2 |
| Genes related to primary cilium development based on crispr 0.4834355691475977 0.8966433816384808 0.3699092414788825 1.0 0.9952830506092764 9 A0AVF1,Q9Y496,P63167 3 |
| Head and neck squamous cell carcinoma 0.446718062433861 0.8827793390513009 0.3773555056271473 1.0 0.9952830506092764 13 P31751,P62942,P42345,P11802 4 |
| Insulin signaling in adipocytes diabetic condition 0.690379847405359 0.8694484616882746 0.384601886061783 1.0 0.9952830506092764 4 P42345 1 |
| Insulin signaling in adipocytes normal condition 0.690379847405359 0.8694484616882746 0.384601886061783 1.0 0.9952830506092764 4 P42345 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.4317155701725899 0.862936031552867 0.3881726386452788 1.0 0.9962542399565524 14 P42166,P11802,Q9UPY3,P48729,O60725,P50402,P25054 7 |
| 15q112 copy number variation syndrome 0.6834181309394568 0.8442836981337983 0.3985108933855659 1.0 1.0 4 Q06787 1 |
| Sars coronavirus and innate immunity 0.7663859392164043 0.8438628888510263 0.398746028076729 1.0 1.0 2 Q7Z434 1 |
| Follicle stimulating hormone fsh signaling pathway 0.5062842092550186 0.8102207371589459 0.4178133210974089 1.0 1.0 7 Q15382,P42345,P28482 3 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.7835164835164842 0.7983447435678085 0.4246704595955637 1.0 1.0 3 Q13155,P48507 2 |
| Ethanol metabolism production of ros by cyp2e1 0.7517392896374954 0.7893005827985189 0.4299363460938683 1.0 1.0 2 P36507 1 |
| Mapk pathway in congenital thyroid cancer 0.7517392896374954 0.7893005827985189 0.4299363460938683 1.0 1.0 2 P36507 1 |
| Congenital generalized lipodystrophy cgl 0.7499084584401319 0.7825414053347384 0.4338964617098382 1.0 1.0 2 P31751 1 |
| Disruption of postsynaptic signaling by cnv 0.4949808951210718 0.7597968230901878 0.447376042195172 1.0 1.0 7 Q14168,Q06787 2 |
| Cysteine and methionine catabolism 0.5594086082154296 0.74557718222018 0.4559228708985605 1.0 1.0 5 Q99707,P25325 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.4906411707298291 0.7405905451549023 0.4589417424916029 1.0 1.0 7 Q15392 1 |
| Micrornas in cardiomyocyte hypertrophy 0.3829400289724598 0.7180185548525799 0.4727458461826983 1.0 1.0 16 P31751,P46734,Q13144,P42345,P49841,P36507 6 |
| Type i interferon induction and signaling during sarscov2 infection 0.757436214545486 0.712508159062894 0.4761501608479221 1.0 1.0 3 Q7Z434 1 |
| Bladder cancer 0.5492436764557133 0.7061937593076395 0.4800676508024168 1.0 1.0 5 P36507,P11802,Q02750 3 |
| Tolllike receptor signaling pathway 0.4240630136066158 0.6957801520602483 0.486566520917147 1.0 1.0 12 P31751,P46734,Q13546,Q14790,P36507,P42224 6 |
| Mirna biogenesis 0.75150262127665 0.6933228290725857 0.4881069795284083 1.0 1.0 3 Q9UPY3 1 |
| Estrogen receptor pathway 0.7450268069888001 0.6725457853744088 0.5012363025116195 1.0 1.0 3 Q15067 1 |
| Nitric oxide metabolism in cystic fibrosis 0.5358698775454555 0.6550929667922332 0.512407900071641 1.0 1.0 5 Q99873,Q86X55 2 |
| Nanoparticle triggered regulated necrosis 0.7383957460311374 0.6514543207766805 0.5147532549933713 1.0 1.0 3 Q13546 1 |
| Ovarian infertility 0.7088978396191872 0.6353801175217084 0.5251805322336163 1.0 1.0 2 P11802 1 |
| Clear cell renal cell carcinoma pathways 0.3453062464901105 0.6300153915720942 0.5286845140985788 1.0 1.0 34 Q13085,Q13501,O00469,Q86U86,Q15382,P42345,P09972,P14618,O00763 9 |
| Lipid metabolism pathway 0.4244112276069929 0.6114765147239271 0.5408841615534057 1.0 1.0 9 Q13085 1 |
| Tca cycle and deficiency of pyruvate dehydrogenase complex pdhc 0.3742634023297507 0.6065089564019497 0.5441768367386759 1.0 1.0 15 P11498 1 |
| Type ii diabetes mellitus 0.7001098498718419 0.6050676343876032 0.5451340583180675 1.0 1.0 2 P42345 1 |
| Interferon type i signaling pathways 0.3832825297536845 0.5994998609992929 0.5488396027425391 1.0 1.0 14 P42345,P46734 2 |
| Methionine de novo and salvage pathway 0.4564931071773243 0.5932197226714783 0.5530341151224487 1.0 1.0 7 Q99707,Q13126 2 |
| Pi3kaktmtor vitd3 signaling 0.6103382689291053 0.5901290833113368 0.5551041119429385 1.0 1.0 4 P42345 1 |
| Mitochondrial fatty acid synthesis pathway 0.7187065426510753 0.5900201561210165 0.5551771363916502 1.0 1.0 3 Q8IVS2 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4521239469790705 0.5749412767187007 0.5653310128023266 1.0 1.0 7 Q13418,P42345,P49841 3 |
| Measles virus infection 0.3321012201896103 0.5728203371229645 0.566766347595588 1.0 1.0 24 Q7Z434,P11802,P24941,O15372,P67870,P54652,Q14790,P42574,P42224 9 |
| Microtubule cytoskeleton regulation 0.3457768400310096 0.5709101383271216 0.5680605582010505 1.0 1.0 17 P60953,Q99661,Q16512,Q7Z460,Q16555,P25054,P49841,Q13153 8 |
| Hostpathogen interaction of human coronaviruses autophagy 0.7102564102564114 0.5642492498581507 0.5725845145936286 1.0 1.0 3 O95352,P42345 2 |
| Alpha 6 beta 4 signaling pathway 0.4678092769077595 0.5519272423887462 0.5809982028592247 1.0 1.0 6 P62993,P42345,P28482 3 |
| Cell cycle 0.2847632296609108 0.5414610095868094 0.5881898653302147 1.0 1.0 46 P11802,O96017,P24941,P33993,P78527,P53350,Q9H1A4,P63208,O43683,Q9UJX4,P14635 11 |
| Eukaryotic transcription initiation 0.3617086382793112 0.5401627583043033 0.5890847933778651 1.0 1.0 15 P19447,Q9GZS1,Q13418,P18074,P29083 5 |
| Hepatocyte growth factor receptor signaling 0.4124799685186512 0.5391991815760048 0.589749425019571 1.0 1.0 10 Q02750,Q16512,P62993,P28482,P36507 5 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.7003663003663012 0.5345825618506901 0.592938544607104 1.0 1.0 3 P36507,Q02750 2 |
| Kallmann syndrome 0.7003663003663012 0.5345825618506901 0.592938544607104 1.0 1.0 3 P62993,P36507 2 |
| Serotonin receptor 467 and nr3c signaling 0.7003663003663012 0.5345825618506901 0.592938544607104 1.0 1.0 3 P36507,Q02750 2 |
| Mthfr deficiency 0.4398408837294008 0.5244075266050787 0.599995122648576 1.0 1.0 7 P35790 1 |
| Energy metabolism 0.40504506489655 0.5237128094853359 0.6004783048657121 1.0 1.0 9 Q99873,P49841,Q96EB6,Q9BQG0 4 |
| Nad biosynthetic pathways 0.5815328949676137 0.4970791469185878 0.6191332392468669 1.0 1.0 4 Q9UGN5,Q96EB6 2 |
| Oncostatin m signaling pathway 0.3532132841686174 0.4967076256765912 0.6193952441363848 1.0 1.0 15 P55210,P24941,Q02750,P42345,P36507,P42574,P42224 7 |
| Dna mismatch repair 0.3277899212337409 0.484610436460512 0.6279527091651145 1.0 1.0 18 Q9NR33,Q9UQ84,P15927,P40938 4 |
| Translation factors 0.3133169678900893 0.4807988315266364 0.6306594807946668 1.0 1.0 36 P20042,Q13144,Q13347,Q05639,O75153,Q9NR50,P55010,O15372,P49770,O00303,O60841 11 |
| Extracellular vesiclemediated signaling in recipient cells 0.5750135894915456 0.4767658288844362 0.6335288810457156 1.0 1.0 4 P42345 1 |
| Transcription cofactors ski and skil protein partners 0.6598315635298426 0.4730603406985588 0.6361701302782121 1.0 1.0 2 O14744 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.568893471326508 0.4579731728883133 0.6469717150511722 1.0 1.0 4 P25054,P48729 2 |
| Nucleotide excision repair 0.3092472703892071 0.4553661055396631 0.6488458755251056 1.0 1.0 23 P41440,P15927,P40938,P19447,Q9NR33,Q13620,P18074 7 |
| Wnt signaling pathway 0.3728897195663501 0.451425381307189 0.6516829936862816 1.0 1.0 12 P25054,P48729,P42345 3 |
| Glioblastoma signaling pathways 0.3618338339026469 0.4490522460221192 0.6533939679473262 1.0 1.0 13 P31751,P24941,P11802,Q02750,P46734,P36507 6 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.3820511188990861 0.4480927990670285 0.6540862247526529 1.0 1.0 11 P55210,P31751,Q13546,P49841,P42574 5 |
| Neural crest cell migration during development 0.4198410204198393 0.4451948223802264 0.65617896811683 1.0 1.0 7 P31751,Q16512,Q13177 3 |
| Mirna regulation of dna damage response 0.3099890722440173 0.4436310564166099 0.6573093484188126 1.0 1.0 22 P41440,P15927,P11802,P24941,P33993,P78527,P14635 7 |
| Cardiac progenitor differentiation 0.6495789088246064 0.4415305939880529 0.6588289180094071 1.0 1.0 2 P49841 1 |
| Mirna regulation of p53 pathway in prostate cancer 0.5630948599416243 0.4404257706044479 0.6596287634382798 1.0 1.0 4 O96017,P42574 2 |
| Cell migration and invasion through p75ntr 0.4363363312641561 0.432919421521191 0.6650733099959591 1.0 1.0 6 P31751 1 |
| Metapathway biotransformation phase i and ii 0.3025067243049937 0.3893623008452901 0.697008155602072 1.0 1.0 21 Q99735,Q9H0A0,Q86UY6,P07099,Q9GZZ1 5 |
| Joubert syndrome 0.3078516859527158 0.3812167675258756 0.7030424081780102 1.0 1.0 18 P61006,Q10713,P42345,Q15154 4 |
| Tnfalpha signaling pathway 0.3067997628658604 0.3760526117542497 0.7068777831979824 1.0 1.0 18 P55210,P46734,Q13546,P63208,P53350,Q14790,P42574 7 |
| 16p112 distal deletion syndrome 0.4552673492949551 0.372169712770856 0.7097664947169715 1.0 1.0 5 Q99873,Q8WWM7 2 |
| Interactome of polycomb repressive complex 2 prc2 0.5376787606765734 0.3667253059240958 0.7138239283547956 1.0 1.0 4 Q9UPQ4 1 |
| Pi3kakt signaling pathway 0.3127730865145312 0.3622679652748044 0.7171517946686885 1.0 1.0 31 P31751,P11802,Q02750,P24941,Q16512,Q15382,P42345,P63151,P49841,P36507 10 |
| Il10 antiinflammatory signaling pathway 0.4468092865883114 0.3458317645098696 0.7294691517769403 1.0 1.0 5 P09601 1 |
| Base excision repair 0.3205238496743204 0.3428573966796818 0.7317057437120054 1.0 1.0 15 P18887,Q9NR33 2 |
| Erbb signaling pathway 0.3277693896332593 0.3369878173543873 0.7361260838809152 1.0 1.0 14 P31751,Q13177,Q02750,Q16512,P62993,P42345,P28482,P49841,P36507 9 |
| Methylation pathways 0.6260073260073274 0.3323433994689453 0.7396299724035429 1.0 1.0 3 P21964,Q9NZL9 2 |
| Nucleotide excision repair in xeroderma pigmentosum 0.3029372519028629 0.3233668584920617 0.7464174254951712 1.0 1.0 30 P41440,P15927,P40938,P19447,Q9NR33,P18887,Q13620,P18074 8 |
| Osteoblast differentiation and related diseases 0.4029995066584596 0.3182529854089566 0.7502930438513351 1.0 1.0 6 Q8NEB9,P28482,P78527,P42224 4 |
| Nanoparticlemediated activation of receptor signaling 0.3821526318791636 0.3088390290633273 0.7574439785428102 1.0 1.0 7 P62993,P36507,P28482,Q02750 4 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3984717886853245 0.3037614383927 0.7613096470404375 1.0 1.0 6 Q13546,Q7Z434 2 |
| Effect of progerin on genes involved in hutchinsongilford progeria syndrome 0.3498039732751983 0.3000230091389417 0.7641596048721973 1.0 1.0 9 Q13330,Q92769,O60341 3 |
| Alzheimers disease and mirna effects 0.2514431055913241 0.2993696718378873 0.7646580000138294 1.0 1.0 83 P28070,P68371,Q15008,P42345,Q14790,O14654,Q8NEB9,O43242,Q96IX5,P07384,P31751,P20618,P62333,Q02750,P12235,P05141,P07437,P55036,P55210,P19784,Q9H0B6,P48729,P28074,P45880,P60900,P49721,P25054,P36507,P42574,Q13885,Q9NSK0,P67870,P25786,P49841,P16615 35 |
| Vitamin dsensitive calcium signaling in depression 0.4283088606942103 0.2910734611008216 0.7709951365482814 1.0 1.0 5 Q8NB78 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.2798273856037794 0.2901491095468659 0.7717021669203925 1.0 1.0 22 Q14739,Q15392,P35610,O00767 4 |
| Insulin signaling 0.291295511891272 0.2900612755082847 0.7717693604692895 1.0 1.0 33 P31751,P41440,Q02750,Q6ZWJ1,P46734,P46976,Q9Y496,Q15382,P42345,O14654,P49841,P36507 12 |
| Splicing factor nova regulated synaptic proteins 0.3157405528580473 0.2885401346859256 0.7729333131595733 1.0 1.0 14 O14936 1 |
| Angiopoietinlike protein 8 regulatory pathway 0.2775803012361566 0.2637468696332531 0.7919749770904658 1.0 1.0 25 P31751,P41440,P49840,O00767,Q02750,Q9UPT5,P46734,Q15382,P42345,P28482,O14654,Q8NEB9,P49841,P36507 14 |
| Burn wound healing 0.3391763256441297 0.2517426390578199 0.8012399969054347 1.0 1.0 10 O60885,P07737 2 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.3783583585842622 0.242935772036603 0.8080551534300993 1.0 1.0 6 P42224,P28482,P36507,Q02750 4 |
| Small cell lung cancer 0.3264184434642175 0.2361116034238157 0.8133460702274184 1.0 1.0 11 P31751,P24941,P11802,P63208,P42574 5 |
| Alzheimers disease 0.2380744042302358 0.2354493466954887 0.813859989246073 1.0 1.0 81 P28070,P68371,Q15008,P42345,Q14790,O14654,Q8NEB9,O43242,P07384,P31751,P20618,P62333,Q02750,P12235,P05141,P07437,P55036,P55210,P19784,Q9H0B6,P48729,P28074,P45880,P60900,P49721,P25054,P36507,P42574,Q13885,Q9NSK0,P67870,P25786,P49841,P16615 34 |
| Dna repair pathways full network 0.2367011956470432 0.2300011153383938 0.8180909030344028 1.0 1.0 44 P41440,P15927,P40938,P19447,Q9NR33,P18887,Q9UGN5,Q13620,P78527,P18074,Q9UQ84 11 |
| 7q1123 copy number variation syndrome 0.254556676279841 0.2284311682005072 0.8193110611812255 1.0 1.0 39 Q13085,Q13501,P54652,O00763 4 |
| Wnt signaling 0.3064064900884782 0.2274593459822689 0.8200665779481513 1.0 1.0 13 P25054,P48729,P67870 3 |
| Leptin signaling pathway 0.2655017787711908 0.2249084879783942 0.8220504660016827 1.0 1.0 24 P60953,Q13085,Q02750,P42345,P49841,P36507,Q07666,O00763,P42224 9 |
| Intraflagellar transport proteins binding to dynein 0.3718912479174407 0.2246824026109222 0.8222263552998308 1.0 1.0 6 Q96FJ2 1 |
| Endometrial cancer 0.3128761544917585 0.219516659775455 0.8262476037038495 1.0 1.0 12 P31751,Q02750,Q13418,P25054,P49841,P36507 6 |
| Il3 signaling pathway 0.3382259705658134 0.21446697933382 0.8301829145440096 1.0 1.0 8 P62993,Q02750 2 |
| Vitamin b12 disorders 0.5718177497446705 0.2140175897817063 0.8305333403039032 1.0 1.0 3 Q96EY8 1 |
| Pathways affected in adenoid cystic carcinoma 0.2989022733229268 0.2031275931789193 0.839035305046888 1.0 1.0 13 Q96T88,Q9BYW2,P78527,O96017,P36507 5 |
| Mirna regulation of prostate cancer signaling pathways 0.3202039006360162 0.2022063648045687 0.8397553975139518 1.0 1.0 9 Q02750,P62993,P42345,P49841,P36507 5 |
| Kisspeptinkisspeptin receptor system in the ovary 0.3937584990363795 0.2005357032767601 0.8410616378801283 1.0 1.0 5 P31751,P36507,Q02750 3 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3213951922780449 0.1966370629737626 0.8441115647563748 1.0 1.0 10 P25054,P48729,P67870 3 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3192610050274115 0.1904830412876192 0.8489306309926967 1.0 1.0 10 P31751,P24941,Q02750,P28482,P36507 5 |
| Nad metabolism 0.5429997759803851 0.1629236613808659 0.8705785406503219 1.0 1.0 3 Q96EB6 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.2847695045599513 0.1614798690863381 0.8717154654191852 1.0 1.0 13 O15372,Q13347,P20042,P55010 4 |
| Il5 signaling pathway 0.3075371200683551 0.1585039924577497 0.87405967490667 1.0 1.0 10 Q02750,P62993,P28482,P49841,P36507,P42224 6 |
| Autophagy 0.3735569229250608 0.1554319736913396 0.8764807790993976 1.0 1.0 5 P42345 1 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.2565123151050852 0.147170967641004 0.8829970755103003 1.0 1.0 29 P31751,Q13085,Q02750,Q15382,P42345,O14654,P61006,P49841,P36507 9 |
| Orexin receptor pathway 0.2716864350539871 0.1446528418326571 0.884984974197528 1.0 1.0 14 P31350,P11177 2 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3016293807734997 0.1435814058101267 0.8858310245132055 1.0 1.0 10 Q02750,P42345,P28482,P36507,P42224 5 |
| Glycerolipids and glycerophospholipids 0.3601399533301919 0.1288722662781455 0.8974587219457015 1.0 1.0 5 Q9HCL2,O96017 2 |
| Interleukin1 il1 structural pathway 0.2904590179525996 0.1232562393983176 0.9019041924303002 1.0 1.0 9 Q02750,P46734,P28482,P36507,Q16539 5 |
| Cytosolic dnasensing pathway 0.285170663329183 0.1220185585142024 0.902884320524431 1.0 1.0 11 O14802,Q7Z434,Q13546 3 |
| Regulatory circuits of the stat3 signaling pathway 0.3270493846157343 0.1173727147549358 0.9065647050703484 1.0 1.0 6 P42345,P28482 2 |
| Fragile x syndrome 0.2304530913538006 0.1054196561359967 0.916042819626735 1.0 1.0 36 P53985,Q02750,Q9UPY3,P62993,Q7L576,Q15382,Q15334,P42345,P28482,P51452,Q06787,P62136,P50416,P36507,P28288 15 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.4104673613235383 0.0990016895741025 0.9211369286102984 1.0 1.0 4 Q99707 1 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.2785716831858409 0.097494751472828 0.9223335020938412 1.0 1.0 9 O60566 1 |
| Vegfavegfr2 signaling pathway 0.2207297774746675 0.0970448894595533 0.9226907460248512 1.0 1.0 159 P60953,P07814,Q9Y305,Q9Y4L1,Q96PU8,Q9NZB2,P42345,P31689,Q14694,P28289,Q4VCS5,P46777,Q15293,Q02750,P07737,O60885,Q16512,P46734,O15372,P62136,P51571,O00763,P55036,Q13085,P48735,P36507,Q02543,Q01844,Q9Y520,Q96J02,P40429,Q8N3C0,P41240,O15355,P49841,P62280,O43852,Q12800,P42224 39 |
| Hypertrophy model 0.4866349322592457 0.095617078605814 0.9238247005846034 1.0 1.0 2 O75083 1 |
| Mrna processing 0.203906308964031 0.0906909635049581 0.9277381511196536 1.0 1.0 98 P35637,P38159,P61978,P08621,O75533,P23246,O43390,Q14103,Q99873,Q13242,P26599,P31943,Q12872,Q92499,Q99729,Q9UPY3,O60231,P09651,P62314,P14866,P22626,Q00839,Q05048,P55795,Q13523,O15355,Q15233,P62995,P84103 29 |
| Prolactin signaling pathway 0.2201564263766616 0.0858902228287037 0.9315536838412904 1.0 1.0 21 Q02750,Q16512,P42345,P49841,P36507,P42574,P42224 7 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.469284648512814 0.0710335337295841 0.943371066832624 1.0 1.0 3 P48507 1 |
| Peroxiredoxin 2 induced ovarian failure 0.4675276353490912 0.0694911910412086 0.944598644235086 1.0 1.0 3 Q9UGN5 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.3213108381271246 0.0675211818049303 0.946166799861942 1.0 1.0 5 P55210,P42574 2 |
| Ccl18 signaling pathway 0.259059389709772 0.0600008622060245 0.9521549479881086 1.0 1.0 10 P27144 1 |
| Tgfbeta signaling pathway 0.2187287459694879 0.0593085589499578 0.9527063440608048 1.0 1.0 30 P60953,Q13177,Q02750,P62993,P46734,Q9NPI6,P63208,Q96J02,P35658,P36507 10 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.2765455031690457 0.0540765183769305 0.9568742004878285 1.0 1.0 7 P31943,Q8WUM4,P28482,P61020 4 |
| Tumor suppressor activity of smarcb1 0.2459234548814056 0.0435694144061918 0.9652476323042054 1.0 1.0 9 Q15022,P11802 2 |
| Urea cycle and metabolism of amino groups 0.2801613494682777 0.0430306147924195 0.9656771293732782 1.0 1.0 6 P00367,P32322,P19623,P54886,P12277 5 |
| Parkinubiquitin proteasomal system pathway 0.1803386728865574 0.0369324503763853 0.9705388657310496 1.0 1.0 37 P68371,Q13885,P62333,O14936,P54652,O43242,P55036 7 |
| Proteasome degradation 0.1337269511586786 0.0287440366473046 0.9770687346977416 1.0 1.0 41 P28070,P20618,P62333,P28074,P60900,P25786,P49721,O43242,P55036 9 |
| Focal adhesion 0.1820343079460301 0.0266384629393389 0.9787480951461504 1.0 1.0 29 P31751,P60953,Q13177,Q02750,P62993,Q16512,Q13418,P62136,P49841 9 |
| Biomarkers for pyrimidine metabolism disorders 0.279597972090688 0.025814071545849 0.9794056381189238 1.0 1.0 5 P31350,P11172 2 |
| Netrinunc5b signaling pathway 0.2116848548862175 0.025360549190704 0.9797673781640952 1.0 1.0 12 P62136,P36507,P42574,Q02750 4 |
| Mitochondrial gene expression 0.3242946134115009 0.02343543160015 0.9813029424307784 1.0 1.0 4 Q9P2K5,P51610,O00411 3 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.2602277368132274 0.0225456697868103 0.9820126820243368 1.0 1.0 6 Q9H3P2,Q92769,O00267 3 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.3181984621017943 0.0203692648975929 0.9837488018202624 1.0 1.0 2 P28482 1 |
| Metastatic brain tumor 0.2501831501831525 0.0107122965905438 0.9914529874062908 1.0 1.0 3 P60953,Q00534 2 |
| Sleep regulation 0.2788567240747469 0.0088268096611889 0.9929573163025736 1.0 1.0 4 P10515,Q99808,P00813 3 |
| Neural crest cell migration in cancer 0.215344435821554 0.0055498052096634 0.995571918838824 1.0 1.0 8 P31751,Q16512,Q13177 3 |
| Unfolded protein response 0.2502748259435632 0.0046845695065149 0.996262267987623 1.0 1.0 4 Q9Y3I0,Q14790,P05198 3 |
|
|
